Search in:

Advanced search

Canadian Journal of Respiratory, Critical Care, and Sleep Medicine

Revue canadienne des soins respiratoires et critiques et de la médecine du sommeil

Volume 7, 2023 - Issue 5

Submit an article Journal homepage

Views

CrossRef citations to date

Altmetric

History of Respiratory Medicine in Canada

A brief history of lung cancer in Canada: Care, contributions and challenges

Stéphanie Merciera Department of Medicine, University of Ottawa, Ottawa, CanadaView further author information

Stephen Lamb Department of Integrative Oncology, BC Cancer and the Department of Medicine, University of British Columbia, Vancouver, CanadaView further author information

Andrea Bezjakc Department of Radiation Oncology, University of Toronto, Toronto, CanadaView further author information

Charles Buttsd Department of Oncology, University of Alberta, Edmonton, CanadaView further author information

Andrew J. E. Seelye Department of Surgery, University of Ottawa, Ottawa, CanadaView further author information

Paul Wheatley-Pricea Department of Medicine, University of Ottawa, Ottawa, Canada;f Ottawa Hospital Research Institute, Ottawa, CanadaCorrespondence[email protected]
View further author information

Pages 258-269 | Received 25 Apr 2023, Accepted 30 Aug 2023, Published online: 11 Oct 2023

Cite this article
https://doi.org/10.1080/24745332.2023.2255193
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Reprints & Permissions

References

Lung and bronchus cancer statistics. Canadian Cancer Society. Published May 2022. Accessed March 1, 2023 https://cancer.ca/en/cancer-information/cancer-types/lung/statistics.
Google Scholar
Canadian Cancer Statistics Advisory in collaboration with, the Canadian Cancer Society, Statistics Canada and the, Public Health Agency of Canada. Canadian Cancer Statistics: a 2022 special report on cancer prevalence. Published online November 2022. Accessed March 1, 2023. https://cdn.cancer.ca/-/media/files/research/cancer-statistics/2022-statistics/2022-special-report/2022_prevalence_report_final_en.pdf?rev=7755f9f350e845d58e268a59e3be608e&hash=3F3F30CADD8CAF0049636B5A41EDBB13&_gl=1*1xw6vbp*_ga*MTYxNDM2OTAxMi4xNjc3MDEwNjQw*_ga_23YMKBE2C3*MTY3NzAxMDY0MC4xLjEuMTY3NzAxMDg4MC41OS4wLjA.
Google Scholar
Statistics Canada, Government of Canada. Lung cancer is the leading cause of cancer death in Canada. Published January 4, 2022. Accessed March 1, 2023. https://www.statcan.gc.ca/o1/en/plus/238-lung-cancer-leading-cause-cancer-death-canada.
Google Scholar
Lung Cancer Canada. Causes. Lung Cancer Canada. Accessed March 1, 2023. https://www.lungcancercanada.ca/en-CA/Lung-Cancer/Causes.aspx.
Google Scholar
Historical trends in smoking prevalence. | Tobacco Use in Canada. Accessed March 7, 2023. https://uwaterloo.ca/tobacco-use-canada/adult-tobacco-use/smoking-canada/historical-trends-smoking-prevalence.
Google Scholar
Canadian Institute for Health Information. Canada’s International Health System Performance Over 50 Years: examining potential years of life lost. Ottawa, ON: CIHI; 2016.
Google Scholar
Government of Canada SC. The Daily—Canada’s population estimates: age and sex, July 12022. Published September 28, 2022. Accessed June 20, 2023 https://www150.statcan.gc.ca/n1/daily-quotidien/220928/dq220928c-eng.htm.
Google Scholar
Ruan Y, Poirier A, Yong J, et al. Long-term projections of cancer incidence and mortality in Canada: The OncoSim All Cancers Model. Prev Med. 2023;168:107425. doi:10.1016/j.ypmed.2023.107425.
PubMed Web of Science ®Google Scholar
Müller FH. Tabakmißbrauch und Lungencarcinom. Z Krebs-Forsch. 1940;49(1):57–85. doi:10.1007/BF01633114.
Google Scholar
Doll R, Hill AB. Smoking and Carcinoma of the Lung. Br Med J. 1950;2(4682):739–748. doi:10.1136/bmj.2.4682.739.
PubMed Web of Science ®Google Scholar
Wynder EL, Graham EA. Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma; a study of 684 proved cases. J Am Med Assoc. 1950;143(4):329–336. doi:10.1001/jama.1950.02910390001001.
PubMed Web of Science ®Google Scholar
Collishaw N. History of tobacco control in Canada. Published online November 2009. https://www.smoke-free.ca/pdf_1/2009/History%20of%20tobacco%20control%20in%20Canada.pdf.
Google Scholar
Surgeon emeritus: Dr. Norman Delarue, Canada’s first crusader in the antismoking movement, was harassed and teased in the early days. Now, retired after decades as a busy surgeon, he has seen the movement grow and only regrets that smoking will not vanish. Published May 16, 1986. Accessed March 1, 2023. https://digitalarchive.tpl.ca/objects/313436/surgeon-emeritus-dr-norman-delarue-canadas-first-crusade.
Google Scholar
History of the Surgeon General’s Reports on Smoking and Health | CDC. Published May 3, 2022. Accessed March 15, 2023 https://www.cdc.gov/tobacco/sgr/history/index.htm.
Google Scholar
Chenier NM, Robertson J. Tobacco smoking (86-22E). https://publications.gc.ca/Pilot/LoPBdP/CIR/8622-e.htm. Published September 29, 1997. Accessed March 1, 2023. https://publications.gc.ca/Collection-R/LoPBdP/CIR/8622-e.htm#PARLIAMENTARY
Google Scholar
Physicians for a Smoke-Free Canada. The Engineering of Canadian Cigarettes. Accessed March 1, 2023. https://www.smoke-free.ca/pdf_1/Background-design.pdf.
Google Scholar
Appendix Table A Smoking ban legislation in Canadian provinces and municipal bylaws in selected cities. Accessed March 13, 2023. https://www150.statcan.gc.ca/n1/pub/82-003-x/2006008/article/smoking-tabac/t/4060721-eng.htm.
Google Scholar
Tobacco Control Laws. Legislation by Country: Canada. Tobacco Control Laws. Accessed March 13, 2023. https://www.tobaccocontrollaws.org/legislation/canada.
Google Scholar
Jeon J, Holford TR, Levy DT, et al. Smoking and Lung Cancer Mortality in the United States From 2015 to 2065: a comparative modeling approach. Ann Intern Med. 2018;169(10):684–693. doi:10.7326/M18-1250.
PubMed Web of Science ®Google Scholar
Public Health Agency of Canada. Lung Cancer. Published March 2, 2009. Accessed March 13, 2023. https://www.canada.ca/en/public-health/services/chronic-diseases/cancer/lung-cancer.html.
Google Scholar
Stanaway JD, Afshin A, Gakidou E, et al. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 2018;392(10159):1923–1994. doi:10.1016/S0140-6736(18)32225-6.
PubMed Web of Science ®Google Scholar
Radon. Canadian Cancer Society. Accessed March 13, 2023. https://cancer.ca/en/cancer-information/reduce-your-risk/know-your-environment/radon.
Google Scholar
Canada NR. Minerals and the economy. Published January 25, 2018. Accessed March 13, 2023. https://natural-resources.canada.ca/our-natural-resources/minerals-mining/minerals-metals-facts/minerals-and-the-economy/20529.
Google Scholar
Straif K, Cohen A, Samet J. Air Pollution and Cancer. Published online 2013.
Google Scholar
Loomis D, Grosse Y, Lauby-Secretan B, et al. The carcinogenicity of outdoor air pollution. Lancet Oncol. 2013;14(13):1262–1263. doi:10.1016/s1470-2045(13)70487-x.
PubMed Web of Science ®Google Scholar
Brauer M, Brook JR, Christidis T, et al. Mortality–Air Pollution Associations in Low-Exposure Environments (MAPLE): Phase 1. Res Rep Health Eff Inst. 2019;2019:203.
PubMedGoogle Scholar
Myers R, Brauer M, Dummer T, et al. High-ambient air pollution exposure among never smokers versus ever smokers with lung cancer. J Thorac Oncol. 2021;16(11):1850–1858. doi:10.1016/j.jtho.2021.06.015.
PubMed Web of Science ®Google Scholar
Canadian Cancer Statistics Advisory Committee. Canadian Cancer Statistics: A 2020 special report on lung cancer. Published online September 2020. Accessed March 1, 2023 https://cdn.cancer.ca/-/media/files/cancer-information/resources/publications/2020-canadian-cancer-statistics-special-report/2020-canadian-cancer-statistics-special-report-en.pdf.
Google Scholar
Lung Cancer Canada. Lung cancer – An overview of lung cancer. Accessed March 13, 2023. https://www.lungcancercanada.ca/en-CA/Lung-Cancer.aspx.
Google Scholar
Young TK, Kelly JJ, Friborg J, Soininen L, Wong KO. Cancer among circumpolar populations: an emerging public health concern. Int J Circumpolar Health. 2016;75(1):29787. /ijch.v75.29787. doi:10.3402/ijch.v75.29787.
PubMed Web of Science ®Google Scholar
Goss GD, Spaans JN, Huntsman D, et al. Histologic and Genotypic Characterization of Lung Cancer in the Inuit Population of the Eastern Canadian Arctic. Curr Oncol. 2022;29(5):3171–3186. doi:10.3390/curroncol29050258.
PubMed Web of Science ®Google Scholar
Deslauriers J, Griffith Pearson F, Nelems B. Evolution of thoracic surgery in Canada. Can Respir J J Can Thorac Soc. 2015;22(2):e8–e14. doi:10.1155/2015/619089.
Google Scholar
Deslauriers J, Nelems B, Griffith Pearson F. Evolution of Thoracic Surgery in Canada. Hamilton, Ontario, Canada: Decker Intellectual Properties; 2015.
Google Scholar
Maziak DE, Darling GE, Inculet RI, et al. Positron emission tomography in staging early lung cancer: a randomized trial. Ann Intern Med. 2009;151(4):221–228. doi:10.7326/0003-4819-151-4-200908180-00132.
PubMed Web of Science ®Google Scholar
Yasufuku K, Chiyo M, Sekine Y, et al. Real-time endobronchial ultrasound-guided transbronchial needle aspiration of mediastinal and hilar lymph nodes. Chest. 2004;126(1):122–128. doi:10.1378/chest.126.1.122.
PubMed Web of Science ®Google Scholar
Yasufuku K, Pierre A, Darling G, et al. A prospective controlled trial of endobronchial ultrasound-guided transbronchial needle aspiration compared with mediastinoscopy for mediastinal lymph node staging of lung cancer. J Thorac Cardiovasc Surg. 2011;142(6):1393–1400.e1. doi:10.1016/j.jtcvs.2011.08.037.
PubMed Web of Science ®Google Scholar
Grzybowski S, Coy P. Early diagnosis of carcinoma of the lung. Simultaneous screening with chest x-ray and sputum cytology. Cancer. 1970;25(1):113–120. doi:10.1002/1097-0142(197001)25:1<113::AID-CNCR2820250116>3.0.CO;2-0.
PubMed Web of Science ®Google Scholar
Lam S, Hung J, MacAulay C, Jaggi B, Palcic B. Fluorescence imaging of early lung cancer. In: Proceedings of the Twelfth Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE. 1990:1142–1143. doi:10.1109/IEMBS.1990.691668
Google Scholar
Lam S, MacAulay C, Palcic B. Detection and localization of early lung cancer by imaging techniques. Chest. 1993;103(1 Suppl):12S–14S. doi:10.1378/chest.103.1_supplement.12s.
PubMed Web of Science ®Google Scholar
Tremblay A, Taghizadeh N, McWilliams AM, et al. Low prevalence of high-grade lesions detected with autofluorescence bronchoscopy in the setting of lung cancer screening in the pan-Canadian Lung Cancer Screening Study. Chest. 2016;150(5):1015–1022. doi:10.1016/j.chest.2016.04.019.
PubMed Web of Science ®Google Scholar
Tammemägi MC, Katki HA, Hocking WG, et al. Selection criteria for lung-cancer screening. N Engl J Med. 2013;368(8):728–736. doi:10.1056/NEJMoa1211776.
PubMed Web of Science ®Google Scholar
Cressman S, Peacock SJ, Tammemägi MC, et al. The cost-effectiveness of high-risk lung cancer screening and drivers of program efficiency. J Thorac Oncol. 2017;12(8):1210–1222. doi:10.1016/j.jtho.2017.04.021.
PubMed Web of Science ®Google Scholar
Cressman S, Weber MF, Ngo PJ, et al. Economic impact of using risk models for eligibility selection to the International lung screening Trial. Lung Cancer. 2023;176:38–45. doi:10.1016/j.lungcan.2022.12.011.
PubMed Web of Science ®Google Scholar
Tammemagi MC, Schmidt H, Martel S, et al. Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study. Lancet Oncol. 2017;18(11):1523–1531. doi:10.1016/S1470-2045(17)30597-1.
PubMed Web of Science ®Google Scholar
Tammemägi MC, Ruparel M, Tremblay A, et al. USPSTF2013 versus PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort study. Lancet Oncol. 2022;23(1):138–148. doi:10.1016/S1470-2045(21)00590-8.
PubMed Web of Science ®Google Scholar
Barbara AM, Loshak H. Lung-RADS versus pan-canadian early detection of lung cancer study screening for patients at high risk of lung cancer. Can J Health Technol. 2021;1(12). doi:10.51731/cjht.2021.221.
Google Scholar
Bradley SH, Abraham S, Callister ME, et al. Sensitivity of chest X-ray for detecting lung cancer in people presenting with symptoms: a systematic review. Br J Gen Pract. 2019;69(689):e827–e835. doi:10.3399/bjgp19X706853.
PubMed Web of Science ®Google Scholar
Surgery for non–small cell lung cancer. Canadian Cancer Society. Published May 2020. Accessed March 2, 2023. https://cancer.ca/en/cancer-information/cancer-types/lung/treatment/surgery.
Google Scholar
Grondin SC, Schieman C. Thoracic surgery education in Canada. J Thorac Cardiovasc Surg. 2017;153(2):493–497. doi:10.1016/j.jtcvs.2016.09.082.
PubMed Web of Science ®Google Scholar
Archibald E. The technic of total unilateral pneumonectomy. Ann Surg. 1934;100(4):796–811. doi:10.1097/00000658-193410000-00020.
PubMedGoogle Scholar
Churchill ED, Sweet RH, Soutter L, Scannell JG. The surgical management of carcinoma of the lung; a study of the cases treated at the Massachusetts General Hospital from 1930 to 1950. J Thorac Surg. 1950;20(3):349–365. doi:10.1016/S0096-5588(20)31576-2.
PubMedGoogle Scholar
Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg. 1995;60(3):615–623. doi:10.1016/0003-4975(95)00537-u.
PubMed Web of Science ®Google Scholar
O’Reilly D, Botticella A, Barry S, et al. Treatment decisions for resectable non–small-cell lung cancer: Balancing less with more? Am Soc Clin Oncol Educ Book. 2023;(43):e389950. doi:10.1200/EDBK_389950.
PubMedGoogle Scholar
Darling GE, Allen MS, Decker PA, et al. Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial. J Thorac Cardiovasc Surg. 2011;141(3):662–670. doi:10.1016/j.jtcvs.2010.11.008.
PubMed Web of Science ®Google Scholar
Finley RJ, Mayo JR, Grant K, et al. Preoperative computed tomography-guided microcoil localization of small peripheral pulmonary nodules: a prospective randomized controlled trial. J Thorac Cardiovasc Surg. 2015;149(1):26–31. doi:10.1016/j.jtcvs.2014.08.055.
PubMed Web of Science ®Google Scholar
Patterson GA, Ilves R, Ginsberg RJ, Cooper JD, Todd TR, Pearson FG. The value of adjuvant radiotherapy in pulmonary and chest wall resection for bronchogenic carcinoma. Ann Thorac Surg. 1982;34(6):692–697. doi:10.1016/s0003-4975(10)60911-3.
PubMed Web of Science ®Google Scholar
Anraku M, Waddell TK, de Perrot M, et al. Induction chemoradiotherapy facilitates radical resection of T4 non-small cell lung cancer invading the spine. J Thorac Cardiovasc Surg. 2009;137(2):441–447.e1. doi:10.1016/j.jtcvs.2008.09.035.
PubMed Web of Science ®Google Scholar
Shargall Y, de Perrot M, Keshavjee S, et al. 15 years single center experience with surgical resection of the superior vena cava for non-small cell lung cancer. Lung Cancer. 2004;45(3):357–363. doi:10.1016/j.lungcan.2004.02.009.
PubMed Web of Science ®Google Scholar
Patterson GA, Piazza D, Pearson FG, et al. Significance of metastatic disease in subaortic lymph nodes. Ann Thorac Surg. 1987;43(2):155–159. doi:10.1016/s0003-4975(10)60386-4.
PubMed Web of Science ®Google Scholar
Salerno TA, Little JR, Munro DD. Bronchogenic carcinoma with a brain metastasis: a continuing challenge. Ann Thorac Surg. 1979;27(3):235–237. doi:10.1016/s0003-4975(10)63281-x.
PubMed Web of Science ®Google Scholar
Chemotherapy for lung cancer. Canadian Cancer Society. Published May 2020. Accessed March 2, 2023. https://cancer.ca/en/cancer-information/cancer-types/lung/treatment/chemotherapy.
Google Scholar
Immunotherapy for non–small cell lung cancer. Canadian Cancer Society. Published May 2020. Accessed March 1, 2023 https://cancer.ca/en/cancer-information/cancer-types/lung/treatment/immunotherapy.
Google Scholar
Horn L, Mansfield AS, Szczęsna A, et al. First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer. N Engl J Med. 2018;379(23):2220–2229. doi:10.1056/NEJMoa1809064.
PubMed Web of Science ®Google Scholar
Canadian Cancer Trials Group. Lung Disease Site. Accessed. March 1, 2023. https://www.ctg.queensu.ca/public/lung/lung-disease-site.
Google Scholar
Winton T, Livingston R, Johnson D, et al. Vinorelbine plus Cisplatin vs. observation in resected non–small-cell lung cancer. N Engl J Med. 2005;352(25):2589–2597. doi:10.1056/NEJMoa043623.
PubMed Web of Science ®Google Scholar
Butts CA, Ding K, Seymour L, et al. Randomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small-cell lung cancer: updated survival analysis of JBR-10. J Clin Oncol. 2010;28(1):29–34. doi:10.1200/JCO.2009.24.0333.
PubMed Web of Science ®Google Scholar
Immunotherapy showing significant advancements in lung cancer treatment. McGill University Health Centre. Accessed March 1, 2023. https://muhc.ca/news-and-patient-stories/research/immunotherapy-showing-significant-advancements-lung-cancer.
Google Scholar
Forde PM, Spicer J, Lu S, et al. Neoadjuvant Nivolumab plus chemotherapy in resectable lung cancer. N Engl J Med. 2022;386(21):1973–1985. doi:10.1056/NEJMoa2202170.
PubMed Web of Science ®Google Scholar
Olivier T, Prasad V. Neoadjuvant checkpoint inhibition in non-small cell lung cancer: Is earlier unquestionably better than later? Transl Oncol. 2022;24:101505. doi:10.1016/j.tranon.2022.101505.
PubMed Web of Science ®Google Scholar
Rapp E, Pater JL, Willan A, et al. Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer–report of a Canadian multicenter randomized trial. J Clin Oncol. 1988;6(4):633–641. doi:10.1200/JCO.1988.6.4.633.
PubMed Web of Science ®Google Scholar
Group BMJP. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ. 1995;311(7010):899–909. doi:10.1136/bmj.311.7010.899.
PubMedGoogle Scholar
Burkes RL, Ginsberg RJ, Shepherd FA, et al. Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage III unresectable non-small-cell lung cancer: results of the Toronto Phase II Trial. J Clin Oncol. 1992;10(4):580–586. doi:10.1200/JCO.1992.10.4.580.
PubMed Web of Science ®Google Scholar
Burkes RL, Shepherd FA, Blackstein ME, et al. Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage IIIA (T1-3, N2) unresectable non-small-cell lung cancer: final results of the Toronto phase II trial. Lung Cancer. 2005;47(1):103–109. doi:10.1016/j.lungcan.2004.06.004.
PubMed Web of Science ®Google Scholar
Shepherd FA, Dancey J, Ramlau R, et al. Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy. J Clin Oncol. 2000;18(10):2095–2103. doi:10.1200/JCO.2000.18.10.2095.
PubMed Web of Science ®Google Scholar
Shepherd FA, Pereira JR, Ciuleanu T, et al. Erlotinib in previously treated non–small-cell lung cancer. N Engl J Med. 2005;353(2):123–132. ():doi:10.1056/NEJMoa050753.
PubMed Web of Science ®Google Scholar
Murray N, Shah A, Brown E, et al. Alternating chemotherapy and thoracic radiotherapy with concurrent cisplatin-etoposide for limited-stage small-cell carcinoma of the lung. Semin Oncol. 1986;13(3 Suppl 3):24–30.
PubMed Web of Science ®Google Scholar
Evans WK, Feld R, Murray N, et al. Superiority of alternating non-cross-resistant chemotherapy in extensive small cell lung cancer. A multicenter, randomized clinical trial by the National Cancer Institute of Canada. Ann Intern Med. 1987;107(4):451–458. doi:10.7326/0003-4819-107-4-451.
PubMed Web of Science ®Google Scholar
Murray N, Livingston RB, Shepherd FA, et al. Randomized study of CODE versus alternating CAV/EP for extensive-stage small-cell lung cancer: an Intergroup Study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology Group. J Clin Oncol. 1999;17(8):2300–2308. doi:10.1200/JCO.1999.17.8.2300.
PubMed Web of Science ®Google Scholar
Lai SL, Perng RP. Combination versus alternating chemotherapy in small-cell lung cancer. Zhonghua Yi Xue Za Zhi Chin Med J Free China Ed. 2000;63(7):513–520.
PubMedGoogle Scholar
Goodman GE, Crowley JJ, Blasko JC, et al. Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study. J Clin Oncol. 1990;8(1):39–47. doi:10.1200/JCO.1990.8.1.39.
PubMed Web of Science ®Google Scholar
Ueoka H, Kiura K, Tabata M, et al. A randomized trial of hybrid administration of cyclophosphamide, doxorubicin, and vincristine (CAV)/cisplatin and etoposide (PVP) versus sequential administration of CAV-PVP for the treatment of patients with small cell lung carcinoma: results of long term follow-up. Cancer. 1998;83(2):283–290. doi:10.1002/(SICI)1097-0142(19980715)83:2<283::AID-CNCR12>3.0.CO;2-P.
PubMed Web of Science ®Google Scholar
Murray N, Turrisi AT. A review of first-line treatment for small-cell lung cancer. J Thorac Oncol. 2006;1(3):270–278. doi:10.1016/s1556-0864(15)31579-3.
PubMed Web of Science ®Google Scholar
Zhou T, Zhang Z, Luo F, et al. Comparison of first-line treatments for patients with extensive-stage small cell lung cancer: a systematic review and network meta-analysis. JAMA Netw Open. 2020;3(10):e2015748. doi:10.1001/jamanetworkopen.2020.15748.
PubMed Web of Science ®Google Scholar
Celebrating the 60th anniversary of the world’s first cancer treatment with Cobalt-60 radiation. | LHSC. Accessed March 1, 2023. https://www.lhsc.on.ca/about-lhsc/celebrating-the-60th-anniversary-of-the-worlds-first-cancer-treatment-with-cobalt-60.
Google Scholar
Radiation therapy for lung cancer. Canadian Cancer Society. Published May 2020. Accessed March 2, 2023 https://cancer.ca/en/cancer-information/cancer-types/lung/treatment/radiation-therapy.
Google Scholar
Library and Archives Canada, Lund C. Radiation Therapy. 1952. https://recherche-collection-search.bac-lac.gc.ca/eng/home/record?app=fonandcol&IdNumber=4948566&q=e011175867.
Google Scholar
Trials. Canadian Pulmonary Radiotherapy Investigators Group. Accessed April 2, 2023. https://www.capriclinicaltrials.com/trials.html.
Google Scholar
Lung Cancer Canada. Radiotherapy Trials. Accessed. March 1, 2023. https://www.lungcancercanada.ca/en-CA/Lung-Cancer/Clinical-Trials/Radiotherapy-Trials.aspx.
Google Scholar
Who we are | Canadian Cancer Trials Group. Accessed April 5, 2023. https://www.ctg.queensu.ca/public/who-we-are.
Google Scholar
Murray N, Coy P, Pater JL, et al. Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol. 1993;11(2):336–344. doi:10.1200/JCO.1993.11.2.336.
PubMed Web of Science ®Google Scholar
Jaffray DA, Siewerdsen JH, Wong JW, Martinez AA. Flat-panel cone-beam computed tomography for image-guided radiation therapy. Int J Radiat Oncol Biol Phys. 2002;53(5):1337–1349. doi:10.1016/s0360-3016(02)02884-5.
PubMed Web of Science ®Google Scholar
Otto K. Volumetric modulated arc therapy: IMRT in a single gantry arc. Med Phys. 2008;35(1):310–317. doi:10.1118/1.2818738.
PubMed Web of Science ®Google Scholar
Bezjak A, Paulus R, Gaspar LE, et al. Safety and efficacy of a five-fraction stereotactic body radiotherapy schedule for centrally located non-small-cell lung cancer: NRG Oncology/RTOG 0813 Trial. J Clin Oncol. 2019;37(15):1316–1325. doi:10.1200/JCO.18.00622.
PubMed Web of Science ®Google Scholar
Palma DA, Olson R, Harrow S, et al. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial. Lancet. 2019;393(10185):2051–2058. doi:10.1016/S0140-6736(18)32487-5.
PubMed Web of Science ®Google Scholar
Palma DA, Olson R, Harrow S, et al. Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term Results of the SABR-COMET Phase II Randomized Trial. J Clin Oncol. 2020;38(25):2830–2838. doi:10.1200/JCO.20.00818.
PubMed Web of Science ®Google Scholar
Canadian Institute for Health Information. A. Access to Palliative Care in Canada. Published online 2018. https://www.cihi.ca/sites/default/files/document/access-palliative-care-2018-en-web.pdf.
Google Scholar
Pesut B, Thorne S, Huisken A, et al. Is progress being made on Canada’s palliative care framework and action plan? A survey of stakeholder perspectives. BMC Palliat Care. 2022;21(1):182. doi:10.1186/s12904-022-01074-4.
PubMed Web of Science ®Google Scholar
Balfour Mount, MD. CMHF. Accessed March 15, 2023. https://www.cdnmedhall.ca/laureates/balfourmount.
Google Scholar
Canadian Medical Hall of Fame. Canadian Medical Association. Balfour Mount, MD. https://www.cdnmedhall.ca/laureates/balfourmount. Updated 2023. Accessed March 15, 2023.
Google Scholar
Palliative Care Pioneer Dr. Eduardo Bruera Honored by ASCO. ASCO Daily News. Accessed March 15, 2023. 10.1200/ADN.22.200894/full.
Google Scholar
Zimmermann C, Swami N, Krzyzanowska M, et al. Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet. 2014;383(9930):1721–1730. doi:10.1016/S0140-6736(13)62416-2.
PubMed Web of Science ®Google Scholar
Zimmermann C, Swami N, Krzyzanowska M, et al. Perceptions of palliative care among patients with advanced cancer and their caregivers. CMAJ. 2016;188(10):E217–E227. doi:10.1503/cmaj.151171.
PubMed Web of Science ®Google Scholar
Hui D, Hannon B, Zimmermann C, Bruera E. Improving patient and caregiver outcomes in oncology: team-based, timely, and targeted palliative care. CA Cancer J Clin. 2018;68(5):356–376. doi:10.3322/caac.21490.
PubMed Web of Science ®Google Scholar
Freedman OC, Zimmermann C. The role of palliative care in the lung cancer patient: can we improve quality while limiting futile care? Curr Opin Pulm Med. 2009;15(4):321–326. doi:10.1097/MCP.0b013e32832b8a5d.
PubMed Web of Science ®Google Scholar
Moore S, Thabet C, Wheatley-Price P. Brief report: medical assistance in dying in patients with lung cancer. JTO Clin Res Rep. 2022;3(2):100283. doi:10.1016/j.jtocrr.2022.100283.
PubMedGoogle Scholar
Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care. 1991;7(2):6–9. doi:10.1177/082585979100700202.
PubMedGoogle Scholar
Hui D, Bruera E. The Edmonton Symptom Assessment System 25 years later: past, present and future developments. J Pain Symptom Manage. 2017;53(3):630–643. doi:10.1016/j.jpainsymman.2016.10.370.
PubMed Web of Science ®Google Scholar
Osoba D, Bezjak A, Brundage M, et al. Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of The National Cancer Institute of Canada Clinical Trials Group. Eur J Cancer. 2005;41(2):280–287. doi:10.1016/j.ejca.2004.10.017.
PubMed Web of Science ®Google Scholar
Canadian Partnership Against Cancer. Lung cancer and equity: a focus on income and geography. Published online November 2020.
Google Scholar
Organized screening for lung cancer will save lives and resources. Canadian Partnership Against Cancer. Accessed July 20, 2023. https://www.partnershipagainstcancer.ca/topics/lung-screening-resources/.
Google Scholar
Indigenous Services Canada. Annual Report to Parliament 2020. Published online 2020.
Google Scholar
Canadian Partnership Against Cancer. Lung cancer screening in Canada: 2021/2022. Canadian Partnership Against Cancer. Accessed July 20, 2023. https://www.partnershipagainstcancer.ca/topics/lung-cancer-screening-in-canada-2021-2022/programs/.
Google Scholar
Canadian Cancer Research Alliance. Fifteen Years of Investment in Cancer Research in Canada. 2005–2019. Tor CCRA. https://www.ccra-acrc.ca/wp-content/uploads/2022/06/Fifteen_year_EN_reduced_size.pdf. June 2022. Accessed March 1, 2023.
Google Scholar
Lung Health Foundation, Lung Cancer Canada. Start Asking the Right Question About Lung Cancer (Second Edition). The Wrong Question. Published October 2021. Accessed March 1, 2023. https://thewrongquestion.ca/wp-content/uploads/2021/10/Start-Asking-the-Right-Question-About-Lung-Cancer-Second-Edition.pdf.
Google Scholar
Gotfrit J, Jackson A, Shin JJW, Stewart DJ, Mallick R, Wheatley-Price P. Determinants of the Cancer Drug Funding Process in Canada. Curr Oncol. 2022;29(3):1997–2007. doi:10.3390/curroncol29030162.
PubMed Web of Science ®Google Scholar
Berg CD, Schiller JH, Boffetta P, et al. Air pollution and lung cancer: a review by international association for the study of lung cancer early detection and screening committee. J Thorac Oncol. 2023;18(10):P1277–1289. doi:10.1016/j.jtho.2023.05.024.
PubMed Web of Science ®Google Scholar
Lung Cancer Canada. First Line Trials. Accessed March 1, 2023. https://www.lungcancercanada.ca/en-CA/Lung-Cancer/Clinical-Trials/First-Line-Trials.aspx.
Google Scholar
Canada H. Overview of Canada’s Tobacco Strategy. Published May 31, 2018. Accessed July 3, 2023. https://www.canada.ca/en/health-canada/services/publications/healthy-living/canada-tobacco-strategy/overview-canada-tobacco-strategy.html.
Google Scholar

Additional reading

Timmermann C. A History of Lung Cancer: The Recalcitrant Disease. Basingstoke, UK. Palgrave Macmillan Ltd; 2013.
Google Scholar
Brandt AM. The Cigarette Century. New York City, NY, USA. Basic Books; 2007.
Google Scholar
Deslauriers J, Nelems B, Griffith Pearson F. Evolution of Thoracic Surgery in Canada. Hamilton, Ontario, Canada: Decker Intellectual Properties; 2015.
Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

A brief history of lung cancer in Canada: Care, contributions and challenges

References

Additional reading

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

A brief history of lung cancer in Canada: Care, contributions and challenges

References

Additional reading

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date